2m 2m 2m 2m 2m 2m 2m
SEASTAR MEDCL (ICU)
NASDAQ
$3.27-$0.26 (-7.37%)
Price as of Jun 03, 2026 6:22 PM EDT- $14.8MMarket Cap
- -69.30%1-Year Change
- BiotechnologyIndustry
SEASTAR MEDCL (ICU)
$3.27-$0.26 (-7.37%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.2M +814.07% | 135,000 N/A | N/A N/A | N/A N/A | |
Cost of Revenue | 53,000 N/A | 0 N/A | N/A N/A | N/A N/A | |
Gross Profit | 1.2M +774.81% | 135,000 N/A | 0 N/A | 0 -100.00% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -7.5M -17.43% | -9.1M +52.44% | -6.0M +111.88% | -2.8M N/A | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 13.4M -25.71% | 18.0M +26.51% | 14.2M +22.41% | 11.6M +934.26% | |
Operating Profit | -12.2M -31.76% | -17.8M +25.56% | -14.2M +22.41% | -11.6M +934.26% | |
Interest Income | 325,000 +221.78% | 101,000 N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | -244,000 -77.43% | -1.1M +71.59% | -630,000 N/A | |
Interest Income and Expense and Net | 325,000 +327.27% | -143,000 -86.77% | -1.1M +71.59% | -630,000 -5,429.95% | |
Total Nonoperating Income and Expense | 28,000 +100.40% | -7.0M -41.90% | -12.0M +5.43% | -11.4M N/A | |
Income before Taxes | -12.1M -51.07% | -24.8M -5.36% | -26.2M +13.99% | -23.0M +1,950.17% | |
Income Taxes | 3,000 0.00% | 3,000 N/A | 0 -100.00% | 1,000 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -12.2M -51.07% | -24.8M -5.34% | -26.2M +13.99% | -23.0M -30,654.85% | |
Net Income from Continuing Operations Applicable to Common | -12.1M -51.07% | -24.8M -5.36% | -26.2M +13.99% | -23.0M -30,653.53% | |
Basic EPS and Net Income | -5.86 -11.61% | -6.63 +447.93% | -1.21 -56.79% | -2.80 -7,100.00% | |
Diluted EPS and Net Income | -5.86 -11.61% | -6.63 +447.93% | -1.21 -56.79% | -2.80 -7,100.00% | |
Basic Weighted Average Shares | 2.1M -44.62% | 3.7M -82.72% | 21.7M +163.91% | 8.2M -32.73% | |
Diluted Weighted Average Shares | 2.1M -44.62% | 3.7M -82.72% | 21.7M +163.91% | 8.2M -32.73% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 12.0M +558.60% | 1.8M +933.52% | 176,000 +274.47% | 47,000 -8.86% | |
Short-Term Investments | N/A N/A | 500,000 N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 12.0M +416.60% | 2.3M +1,217.61% | 176,000 +274.47% | 47,000 -8.86% | |
Total Current Assets | 13.6M +260.59% | 3.8M +63.17% | 2.3M -23.98% | 3.0M +4,473.39% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Assets | 578,000 -35.20% | 892,000 -25.98% | 1.2M +60,150.00% | 2,000 -100.00% | |
Total Assets | 14.2M +203.95% | 4.7M +32.59% | 3.5M -26.31% | 4.8M -95.50% | |
Income Taxes Payable | 2.3M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 525,000 -8.54% | 574,000 -87.90% | 4.7M +302.72% | 1.2M +831.87% | |
Total Current Liabilities | 3.7M -45.30% | 6.8M -47.56% | 13.0M +143.85% | 5.3M +1,320.22% | |
Total Long-Term Debt | 0 N/A | 0 -100.00% | 4.3M -43.32% | 7.7M N/A | |
Total Long-Term Liabilities | 22,952 N/A | 0 -100.00% | 4.1M -45.86% | 7.7M +10.41% | |
Total Liabilities | 3.7M -45.30% | 6.8M -60.65% | 17.4M +33.69% | 13.0M +18.96% | |
Retained Earnings | -151.7M +8.71% | -139.6M +21.64% | -114.7M +15.51% | -99.3M +840.06% | |
Total Stockholders Equity | 10.4M +577.14% | -2.2M -84.26% | -13.9M +68.43% | -8.2M -22.06% | |
Total Shares Outstanding | 3.8M -35.68% | 6.0M -87.45% | 47.6M +274.93% | 12.7M +390.81% | |
Cash Flow | |||||
Cash from Operating Activities | -13.6M -15.04% | -16.0M +55.63% | -10.3M +31.96% | -7.8M +566.25% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 23.8M +34.62% | 17.6M +69.48% | 10.4M +42.05% | 7.3M -93.13% | |
Financials Ratio | |||||
Gross Margin | 95.71% -4.29% | 100.00% N/A | N/A N/A | N/A N/A | |
Operating Margin | -986.63% -92.53% | -13,216.30% N/A | N/A N/A | N/A N/A | |
Return on Assets | -129.15% -78.75% | -607.76% -4.08% | -633.62% +1,423.99% | -41.58% N/A | |
Return on Equity | -295.15% -195.41% | 309.35% +30.34% | 237.34% -3.05% | 244.81% N/A | |
Revenue Growth | 814.07% N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 3.63 +559.24% | 0.55 +211.19% | 0.18 -68.83% | 0.57 N/A | |
Cash Ratio | 3.20 +1,104.02% | 0.27 +1,869.63% | 0.01 +53.41% | 0.009 N/A | |
Debt-to-Equity Ratio | 0.05 +119.17% | -0.26 -59.84% | -0.65 -38.94% | -1.07 N/A | |
Debt-to-Assets Ratio | 0.04 -69.89% | 0.12 -95.23% | 2.59 +39.56% | 1.85 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow